measuregroup/AID104079

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103204174_AID104079_PMID8182698_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103204131_AID104079_PMID8182698_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103204173_AID104079_PMID8182698_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID124974065_AID104079_PMID8182698_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103204132_AID104079_PMID8182698_VALUE2
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID31
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	In vitro cytotoxicity against human mammary carcinoma cells 180 fold resistant to adriamycin MCF7-R
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103204131 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID124974065 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103204173 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103204174 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103204132
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID104079

Total number of triples: 15.